Councils - Pathology



Scientific Council on Pathology



NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 12 Scientific Councils.



2016 ANNUAL MEETING:

PAST COUNCIL MEETING
Friday, April 7, 2017, 11:30 AM - 1:30 PM
in Coronado A-C of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions

AMR Inflammatory Burden Multicenter Study Meeting
Thursday, April 28, 2016, 7:00 PM - 9:00 PM
Park Tower 8216, Marriott Wardman Park Hotel, Washington, DC
Summary Proposal (word doc)



LINKS NEWSLETTER

Issues focusing on Pathology:

March 2016
March 2016
March 2015
November 2014
December 2013
August 2013
August 2012
August 2011 (PDF)



COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Robert F. Padera, MD, PhD (2021)
Brigham & Women's Hospital
Department of Pathology
Boston, MA, USA
rpadera@partners.org

Dr. Padera received B.S. degrees in both Biomedical Engineering and Chemical Engineering from Northwestern University in 1991, a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology (HST) in 1998 and an M.D. from Harvard Medical School (HMS) in 2000. After medical school, he received his residency training in Anatomic Pathology at the Brigham and Women’s Hospital (BWH), with further fellowship training in cardiovascular, pulmonary, and autopsy pathology, and spent a year as a medical device pathology fellow. He has co-authored approximately 140 original publications in the areas of biomaterials, medical devices, cardiovascular and pulmonary pathology, and has co-authored several book chapters on cardiovascular pathology and cardiovascular medical devices. He is an Attending Pathologist at BWH and Children’s Hospital Boston (CHB), an Associate Professor of Pathology at HMS and Primary Faculty within HST. He is the Director of the Autopsy Service at BWH. His current clinical responsibilities include cardiac and pulmonary surgical pathology with a focus on transplant pathology, autopsy pathology and perinatal congenital heart disease pathology at BWH, and cardiovascular pathology in the Cardiac Registry at CHB. He is the co-director of the first-year HST pathology course at HMS, and teaches in many other HMS pre-clinical medical and graduate courses, as well as in engineering and business courses at MIT. The major focus of his research is in medical device pathology and device development, particularly in the cardiovascular system.



COUNCIL VICE CHAIR:

Fiorella Calabrese, MD (2023)
University of Padova
Padova, ITALY
fiorella.calabrese@unipd.it

Bio coming soon...



COUNCIL PAST CHAIR:

Martin J. Goddard, FRCS MRCPa (2019)
Papworth Hospital
Pathology Department
Papworth Everard
Cambridge, UNITED KINGDOM
44-1480-364-304
martin.goddard@papworth.nhs.uk

Dr Martin Goddard was appointed as a Consultant Histopathologist at Papworth Hospital in 1996. He provides a full range of diagnostic cardio thoracic pathology. He is the clinical lead for cardiac pathology including cardiac transplantation. He is Chairman of the National Cardiac Pathology Network and receives referred hearts from cases of Sudden Adult Death. His major research interests are in the field of cardio vascular disease and cardiac transplantation in particular coronary artery vasculopathy.



BOARD OF DIRECTORS LIAISON:

Dirk Van Raemdonck, MD, PhD (2018)
University Hospital Gasthuisberg
Leuven, BELGIUM
32-16-34-68-23
dirk.vanraemdonck@uz.kuleuven.ac.be

Dirk Van Raemdonck, MD, PHD, is a Professor of Surgery at the Katholieke Universiteit Leuven and Chair of the Leuven University Hospitals Transplant Center, Leuven, Belgium. As a General Thoracic Surgeon he currently serves as the Surgical Director of the Leuven Lung Transplant Program.

He graduated as MD from the Katholieke Universiteit Leuven in 1984. He finished his training in general surgery in 1990 and in thoracic surgery in 1992. He was a registrar in thoracic surgery at the East Birmingham Hospital, Birmingham, U.K in 1990 (Prof HR Matthews), research fellow at the Memorial Sloan-Kettering Cancer Center, New York, N.Y. in 1991 (Dr RJ Ginsberg), and cardiothoracic transplant fellow at the Freeman Hospital, Newcastle-upon-Tyne, U.K. in 1991 (Prof JH Dark). He obtained his PHD degree from the Katholieke Universiteit Leuven in 1998. His main research topic is lung transplantation with particular interest in primary graft dysfunction, donation from donors after circulatory death, and ex-vivo lung perfusion.

He is a current Board member A of Eurotransplant International Foundation since 2005 and previously served as the President of the European Society of Thoracic Surgeons (2012-2013) and as chair of the Thoracic Committee within the European Society for Organ Transplantation (2006-2012).




EDUCATION WORKFORCE LEADER:

TBD









I2C2 WORKFORCE LEADER:

Annalisa Angelini, MD (2018)
University of Padua
Padua, ITALY
annalisa.angelini@unipd.it

Bio coming soon...



STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Anja C Roden, MD (2019)
Mayo Clinic Rochester
Rochester, MN, USA
507-284-1192
roden.anja@mayo.edu

Dr. Roden is a consultant in the Department of Laboratory Medicine and Pathology at the Mayo Clinic Rochester, MN, USA. She holds the academic rank of Associate Professor of Pathology. Her areas of expertise include thoracic pathology, pulmonary and cardiac transplant pathology and surgical pathology.  Dr. Roden also serves as the Medical Director of the Immunostains Laboratory and chairs the Lung and Heart Transplant Pathology Working Group.  Dr. Roden studied medicine at the Humboldt University of Berlin and at the Technical University of Dresden in Germany. After a residency in General Surgery and research training in cancer immunology, Dr. Roden completed her residency in Anatomic and Clinical Pathology followed by a fellowship in Surgical Pathology at the Mayo Clinic Rochester.  Dr. Roden concluded her training with a Mayo scholarship in Pulmonary Pathology. She is board certified in Anatomic and Clinical Pathology. Dr. Roden has a keen interest in lung transplant pathology and studies morphologic, immunophenotypic and ultrastructural findings in lung allograft biopsies.



LINKS NEWSLETTER LIAISON:

Brandon T. Larsen, MD, PHD
University of Arizona Medical Center
Tucson, AZ, USA
blarsen@email.arizona.edu

Bio coming soon...



LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Annalisa Angelini, MD (2020)
University of Padua
Padova, ITALY
390-49-8272260
annalisa.angelini@unipd.it

Bio coming soon...



COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Robert F. Padera, MD, PhD (2021)
Brigham & Women's Hospital
Department of Pathology
Boston, MA, USA
rpadera@partners.org

Dr. Padera received B.S. degrees in both Biomedical Engineering and Chemical Engineering from Northwestern University in 1991, a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology (HST) in 1998 and an M.D. from Harvard Medical School (HMS) in 2000. After medical school, he received his residency training in Anatomic Pathology at the Brigham and Women’s Hospital (BWH), with further fellowship training in cardiovascular, pulmonary, and autopsy pathology, and spent a year as a medical device pathology fellow. He has co-authored approximately 140 original publications in the areas of biomaterials, medical devices, cardiovascular and pulmonary pathology, and has co-authored several book chapters on cardiovascular pathology and cardiovascular medical devices. He is an Attending Pathologist at BWH and Children’s Hospital Boston (CHB), an Associate Professor of Pathology at HMS and Primary Faculty within HST. He is the Director of the Autopsy Service at BWH. His current clinical responsibilities include cardiac and pulmonary surgical pathology with a focus on transplant pathology, autopsy pathology and perinatal congenital heart disease pathology at BWH, and cardiovascular pathology in the Cardiac Registry at CHB. He is the co-director of the first-year HST pathology course at HMS, and teaches in many other HMS pre-clinical medical and graduate courses, as well as in engineering and business courses at MIT. The major focus of his research is in medical device pathology and device development, particularly in the cardiovascular system.


COUNCIL VICE CHAIR:

Fiorella Calabrese, MD (2023)
University of Padova
Padova, ITALY
fiorella.calabrese@unipd.it

Bio coming soon...


COUNCIL PAST CHAIR:

Martin J. Goddard, FRCS MRCPa (2019)
Papworth Hospital
Pathology Department
Papworth Everard
Cambridge, UNITED KINGDOM
44-1480-364-304
martin.goddard@papworth.nhs.uk

Dr Martin Goddard was appointed as a Consultant Histopathologist at Papworth Hospital in 1996. He provides a full range of diagnostic cardio thoracic pathology. He is the clinical lead for cardiac pathology including cardiac transplantation. He is Chairman of the National Cardiac Pathology Network and receives referred hearts from cases of Sudden Adult Death. His major research interests are in the field of cardio vascular disease and cardiac transplantation in particular coronary artery vasculopathy.


BOARD OF DIRECTORS LIAISON:

Dirk Van Raemdonck, MD, PhD (2018)
University Hospital Gasthuisberg
Leuven, BELGIUM
32-16-34-68-23
dirk.vanraemdonck@uz.kuleuven.ac.be

Dirk Van Raemdonck, MD, PHD, is a Professor of Surgery at the Katholieke Universiteit Leuven and Chair of the Leuven University Hospitals Transplant Center, Leuven, Belgium. As a General Thoracic Surgeon he currently serves as the Surgical Director of the Leuven Lung Transplant Program.

He graduated as MD from the Katholieke Universiteit Leuven in 1984. He finished his training in general surgery in 1990 and in thoracic surgery in 1992. He was a registrar in thoracic surgery at the East Birmingham Hospital, Birmingham, U.K in 1990 (Prof HR Matthews), research fellow at the Memorial Sloan-Kettering Cancer Center, New York, N.Y. in 1991 (Dr RJ Ginsberg), and cardiothoracic transplant fellow at the Freeman Hospital, Newcastle-upon-Tyne, U.K. in 1991 (Prof JH Dark). He obtained his PHD degree from the Katholieke Universiteit Leuven in 1998. His main research topic is lung transplantation with particular interest in primary graft dysfunction, donation from donors after circulatory death, and ex-vivo lung perfusion.

He is a current Board member A of Eurotransplant International Foundation since 2005 and previously served as the President of the European Society of Thoracic Surgeons (2012-2013) and as chair of the Thoracic Committee within the European Society for Organ Transplantation (2006-2012).



EDUCATION WORKFORCE LEADER:

TBD






I2C2 WORKFORCE LEADER:

Annalisa Angelini, MD (2018)
University of Padua
Padua, ITALY
annalisa.angelini@unipd.it

Bio coming soon...

STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Anja C Roden, MD (2019)
Mayo Clinic Rochester
Rochester, MN, USA
507-284-1192
roden.anja@mayo.edu

Dr. Roden is a consultant in the Department of Laboratory Medicine and Pathology at the Mayo Clinic Rochester, MN, USA. She holds the academic rank of Associate Professor of Pathology. Her areas of expertise include thoracic pathology, pulmonary and cardiac transplant pathology and surgical pathology.  Dr. Roden also serves as the Medical Director of the Immunostains Laboratory and chairs the Lung and Heart Transplant Pathology Working Group.  Dr. Roden studied medicine at the Humboldt University of Berlin and at the Technical University of Dresden in Germany. After a residency in General Surgery and research training in cancer immunology, Dr. Roden completed her residency in Anatomic and Clinical Pathology followed by a fellowship in Surgical Pathology at the Mayo Clinic Rochester.  Dr. Roden concluded her training with a Mayo scholarship in Pulmonary Pathology. She is board certified in Anatomic and Clinical Pathology. Dr. Roden has a keen interest in lung transplant pathology and studies morphologic, immunophenotypic and ultrastructural findings in lung allograft biopsies.


LINKS NEWSLETTER LIAISON:

Brandon T. Larsen, MD, PHD
University of Arizona Medical Center
Tucson, AZ, USA
blarsen@email.arizona.edu

Bio coming soon...

LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Annalisa Angelini, MD (2020)
University of Padua
Padova, ITALY
390-49-8272260
annalisa.angelini@unipd.it

Bio coming soon...


Text SizeIncrease Font SizeDecrease Font Size